Percisio, the French medtech startup developing computer-vision guidance systems for image-guided medical procedures, has been selected for incubation at Paris Biotech Santé, one of France's leading life-sciences incubators, hosted at the Université Paris Cité Faculty of Medicine.
A favorable committee review
On March 11, 2026, Percisio co-founders Frédéric Lesage (CEO) and Benoit Marcot (CTO) presented the company's technology to Paris Biotech Santé's evaluation committee. The incubator subsequently confirmed the committee's favorable opinion, highlighting the agile, cost-effective design of Percisio's device as a potential facilitator for interventional radiology procedures.
What's next
Joining Paris Biotech Santé gives Percisio access to a network of clinicians, researchers, and industry mentors as the company continues to refine its technology and clinical validation.
"Being welcomed into Paris Biotech Santé is a strong vote of confidence in what we're building. It places us alongside some of the best life-sciences ventures in France and gives us direct access to the clinical and scientific expertise we need to bring Percisio to patients." — Frédéric Lesage, CEO of Percisio
About Percisio
Percisio is dedicated to revolutionizing medical procedures through cutting-edge computer vision technology. Its mission is to make precision-guided interventions accessible, safe, and efficient for healthcare professionals worldwide, improving patient outcomes and advancing the field of image-guided medicine.
About Percisio
Percisio is a medical technology company developing AR-powered guidance for image-guided procedures. The platform enhances precision, reduces radiation exposure, and supports clinicians across interventional radiology and related specialties.
Media inquiries